Novartis CEO: Confident about continued sales growth for rest of year CNBC International News 4:54 1 year ago 443 Далее Скачать
Novartis CEO: Expect continued growth in 2023 CNBC International News 6:12 1 year ago 3 683 Далее Скачать
Focus remains on R&D to drive growth of blockbuster drugs, says Novartis CEO CNBC International News 4:19 1 month ago 236 Далее Скачать
Novartis CEO Vas Narasimhan: Our medicines are starting to take market share and deliver on promises CNBC Television 4:16 1 year ago 5 599 Далее Скачать
Committed to growing over 4% through 2026, says Novartis CEO CNBC International News 1:51 2 years ago 369 Далее Скачать
Novartis CEO: Nations pulling back on health care spending ‘has long-term consequences' Yahoo Finance 7:01 1 year ago 856 Далее Скачать
Novartis CEO Narasimhan on Growth Prospects, Pandemic Disruption Bloomberg Television 11:13 4 years ago 3 297 Далее Скачать
Novartis not joining the 'frenzy' of weight loss drugs, CEO says CNBC International News 3:45 3 months ago 608 Далее Скачать
Ep. 61 - Vas Narasimhan: How New Data Fit Novartis’ Growth Plan BioCentury Video 32:12 5 months ago 74 Далее Скачать
Expect concrete decision before the end of the year on Sandoz, says Novartis CEO CNBC International News 3:34 2 years ago 917 Далее Скачать
'We have reached an endemic environment with Covid,' says Novartis CEO CNBC International News 4:56 1 year ago 953 Далее Скачать
Novartis CEO on the impact of the U.S. election for pharma CNBC International News 3:07 1 month ago 300 Далее Скачать
Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug CNBC Television 3:43 1 year ago 7 033 Далее Скачать
Novartis generated $40 billion in innovative medicine sales, says CEO CNBC Television 3:29 1 year ago 2 239 Далее Скачать
Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine CNBC Television 4:43 6 months ago 2 529 Далее Скачать
